AGT and hypertensive disorder: An interesting methodological solution was presented by the Briones research group, which studied two different groups of mice with hypertension: first, a prevention group in which angiotensin II (AngII)-infused mice were treated with RvD2 (100 ng/mouse) one day before AngII infusion and throughout the experiment (every two days); second, an intervention group in which RvD2 was given at day seven after AngII infusion till the end of the experiment [56].